Skip to content
Med Rx.

Carbonyl Iron + Folic Acid + Ibandronic Acid

Moderate 9 published sources

This interaction is documented in this data source.

Carbonyl Iron + Folic Acid
Checked as Iron + Folic acid
Ibandronic Acid
Checked as Ibandronate

2 documented mechanisms

This source documents more than one distinct mechanism for this pair. Each is shown with its own effect, advice and sources rather than merged into one.

  1. Mechanism 1: Absorption

    Moderate

    via Iron and Ibandronate

    What happens

    INTERVAL: Products containing aluminum, calcium, magnesium and other polyvalent cations such as antacids or vitamin with mineral supplements are likely to interfere with the gastrointestinal absorption of oral bisphosphonates.

    What to do

    Antacids or other oral medications containing aluminum, calcium, magnesium and other polyvalent cations should be administered at least 30 minutes after the bisphosphonate dose.

    9 sources

    1. "Product Information. Boniva (ibandronate)." Roche Laboratories, Nutley, NJ.
    2. "Product Information. Bonefos (clodronate)." Rhone-Poulenc Rorer Canada Inc, Laval, QC.
    3. "Product Information. Skelid (tilundronate)." Sanofi Winthrop Pharmaceuticals, New York, NY.
    4. Darcy PF "Nutrient-drug interactions." Adverse Drug React Toxicol Rev 14 (1995): 233-54
    5. "Product Information. Fosamax (alendronate)." Merck & Co, Inc, West Point, PA.
    6. "Product Information. Actonel (risedronate)." Procter and Gamble Pharmaceuticals, Cincinnati, OH.
    7. "Product Information. Boniva (ibandronate)." Roche Laboratories, Nutley, NJ.
    8. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
    Show all 9 sources
    1. Cerner Multum, Inc. "Australian Product Information." O 0

  2. Mechanism 2: Unknown

    Listed, not described

    via Folic acid and Ibandronate

    The source lists this pair here and publishes no description, mechanism or citation for it.

    No sources recorded

Keep checking